FOCUS PHARMA
ActiveSummary
FOCUS PHARMA has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€91,912) and a net result of -€20,562. Equity is shrinking by about 63% per year across the filed financial years. Its solvency ranks better than 5% of 9,723 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 22 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 24514C0086/00N000 | Flanders | 9,445 m² | 1 · 412 m² | 7.3 m · 2 |